CERO THERAPEUTICS HOLDINGS, INC. Quarterly Interest Expense in USD from Q1 2023 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Cero Therapeutics Holdings, Inc. quarterly Interest Expense history and growth rate from Q1 2023 to Q1 2024.
  • Cero Therapeutics Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $14.4K.
Interest Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $14.4K +$14.5K Feb 14, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 -$4.81K Jan 1, 2024 Feb 13, 2024 10-Q 2024-05-17
Q1 2023 -$16 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.